Margaret Hamburg, M.D.
Co-president, InterAcademy Partnership
Margaret A. Hamburg, MD, Joins NTI as Interim Vice President for NTI | bio
NTI board member Margaret A. Hamburg, MD, is joining NTI’s leadership to serve as interim vice president of the NTI | bio program in February. Hamburg, an internationally recognized leader in public health and medicine, replaces Beth Cameron, PhD, who has moved to the White House to rebuild the National Security Council’s Office of Global Health Security and Biodefense and advance the Biden Administration’s agenda on global health security.
Hamburg’s relationship with NTI goes back to its launch in 2001, when she was named as the organization’s founding senior scientist and biological program vice president. She went on to become commissioner of the Food and Drug Administration and foreign secretary of the National Academy of Medicine.
Hamburg joined NTI’s Board of Directors in 2017.
Stay Informed
Sign up for our newsletter to get the latest on nuclear and biological threats.
More News
NTI | bio Advances Responsible AI Biodesign Tool Development and Use
NTI | bio, CEPI Convene Inaugural Bio Funders Forum to Champion Responsible Innovation and Research Practices
The Bio Funders Forum is a venue for funders of life science research to share best practices and discuss challenges and opportunities for embedding biosafety and biosecurity best practices into their work.
Global Health Security Index Co-Lead Jennifer Nuzzo Elected to National Academy of Medicine
Dr. Jennifer Nuzzo, DrPH, a professor of epidemiology and director of the Pandemic Center at the Brown University School of Public Health, is one of 100 new members to join the National Academy of Medicine (NAM) as part of its 2024 class.
